Reported Earlier, Ultragenyx Prices $350M Public Offering Of 7,435,898 Common Shares At $39/Share And Pre-Funded Warrants
Portfolio Pulse from Benzinga Newsdesk
Ultragenyx has announced a $350 million public offering of 7,435,898 common shares at $39 per share and pre-funded warrants. The offering includes pre-funded warrants to purchase 1,538,501 shares at $38.999 per warrant. The gross proceeds are expected to be $350 million before expenses.
June 14, 2024 | 6:27 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ultragenyx has priced a $350 million public offering of common shares and pre-funded warrants. This move is expected to raise significant capital for the company.
The public offering will provide Ultragenyx with substantial capital, which could be used for growth initiatives or other strategic purposes. This is generally positive for the company's financial health and future prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100